RxDoctor Payments DataLook up a doctor →

Lynn Malec, MD

Pediatric Hematology-Oncology · Milwaukee, WINPI 1629222450

Payments from drug & device makers

$1,361,667in general payments, 2019–2025

Across 807 payments — averaging $1687.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$480K
  • Sanofi$374K
  • CSL Behring$132K
  • Novo Nordisk AS$80K
  • Biomarin Pharmaceutical Inc.$54K
  • Bioverativ Therapeutics Inc.$47K
  • plus $194K from 16 others
$6,520in research payments, 2019–2025

Across 11 payments — averaging $592.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$4K
  • Bioverativ Therapeutics Inc.$3K

What the payments were for

  • Consulting fees$286,68743%
  • Speaking & faculty fees$287,79043%
  • Travel & lodging$79,61012%
  • Food & beverage$9,5741%
  • Education$1920%
  • Gifts$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,361,667 in reported general payments places this provider in the 95th percentile of 46 pediatric hematology-oncology providers in Wisconsin.

See all pediatric hematology-oncology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$589,652
Medicare patients
16
Services billed
86,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric hematology-oncology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →